Your session is about to expire
← Back to Search
Laparoscopic Burch Colposuspension for Irritable Bowel Syndrome (MICRO Trial)
N/A
Waitlist Available
Led By Sarah A Collins, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
English or Spanish speaking and reading
Symptomatic pelvic organ prolapse with any compartment at or beyond the hymen
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks and 3 months following study intervention
Awards & highlights
MICRO Trial Summary
This trial is testing whether adding a Burch colposuspension to a sacrocolpopexy prevents stress urinary incontinence.
Eligible Conditions
- Irritable Bowel Syndrome
- Stress Incontinence
- Sexual Dysfunction
- Urge Urinary Incontinence
- Pelvic Organ Prolapse
MICRO Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMICRO Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 weeks and 3 months following study intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks and 3 months following study intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Urinary Incontinence
Secondary outcome measures
Bowel Symptoms
Pelvic Organ Prolapse
Rate of Surgical Complication
+5 moreMICRO Trial Design
2Treatment groups
Active Control
Group I: ControlActive Control1 Intervention
Patients in this arm will undergo standard laparoscopic or robotic sacrocolpopexy, without the addition of a laparoscopic/robotic Burch colposuspension
Group II: Laparoscopic Burch ColposuspensionActive Control1 Intervention
Patients in this arm will undergo standard laparoscopic or robotic sacrocolpopexy, with the addition of a laparoscopic/robotic Burch colposuspension
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,576 Previous Clinical Trials
911,868 Total Patients Enrolled
1 Trials studying Irritable Bowel Syndrome
40 Patients Enrolled for Irritable Bowel Syndrome
Friends of PrenticeOTHER
3 Previous Clinical Trials
650 Total Patients Enrolled
Sarah A Collins, MDPrincipal InvestigatorNorthwestern University
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger